SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-003255
Filing Date
2015-08-25
Accepted
2015-08-24 17:40:03
Documents
9
Period of Report
2015-07-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT pharmacyte_10q-073115.htm 10-Q 255074
2 CERTIFICATION pharmacyte_10q-ex3101.htm EX-31.1 7831
3 CERTIFICATION pharmacyte_10q-ex3201.htm EX-32.1 3958
  Complete submission text file 0001019687-15-003255.txt   2129024

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE pmcb-20150731.xml EX-101.INS 380494
5 XBRL SCHEMA FILE pmcb-20150731.xsd EX-101.SCH 22602
6 XBRL CALCULATION FILE pmcb-20150731_cal.xml EX-101.CAL 42537
7 XBRL DEFINITION FILE pmcb-20150731_def.xml EX-101.DEF 74924
8 XBRL LABEL FILE pmcb-20150731_lab.xml EX-101.LAB 188891
9 XBRL PRESENTATION FILE pmcb-20150731_pre.xml EX-101.PRE 155239
Mailing Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643
Business Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 151071749
SIC: 2833 Medicinal Chemicals & Botanical Products